These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26720292)

  • 1. Association of Coronary Stent Indication With Postoperative Outcomes Following Noncardiac Surgery.
    Holcomb CN; Hollis RH; Graham LA; Richman JS; Valle JA; Itani KM; Maddox TM; Hawn MT
    JAMA Surg; 2016 May; 151(5):462-9. PubMed ID: 26720292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents.
    Hawn MT; Graham LA; Richman JS; Itani KM; Henderson WG; Maddox TM
    JAMA; 2013 Oct; 310(14):1462-72. PubMed ID: 24101118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete Revascularization Is Associated With an Increased Risk for Major Adverse Cardiovascular Events Among Patients Undergoing Noncardiac Surgery.
    Armstrong EJ; Graham LA; Waldo SW; Valle JA; Maddox TM; Hawn MT
    JACC Cardiovasc Interv; 2017 Feb; 10(4):329-338. PubMed ID: 28161261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
    Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
    Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery.
    Armstrong EJ; Graham L; Waldo SW; Valle JA; Maddox TM; Hawn MT
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):617-627. PubMed ID: 27315550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry.
    Berger PB; Kleiman NS; Pencina MJ; Hsieh WH; Steinhubl SR; Jeremias A; Sonel A; Browne K; Barseness G; Cohen DJ;
    JACC Cardiovasc Interv; 2010 Sep; 3(9):920-7. PubMed ID: 20850090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Incremental Risk of Coronary Stents on Postoperative Adverse Events: A Matched Cohort Study.
    Holcomb CN; Graham LA; Richman JS; Itani KM; Maddox TM; Hawn MT
    Ann Surg; 2016 May; 263(5):924-30. PubMed ID: 25894416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved adverse postoperative outcomes with revised American College of Cardiology/American Heart Association guidelines for patients with cardiac stents.
    Graham LA; Singletary BA; Richman JS; Maddox TM; Itani KM; Hawn MT
    JAMA Surg; 2014 Nov; 149(11):1113-20. PubMed ID: 25188466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incremental risk of noncardiac surgery on adverse cardiac events following coronary stenting.
    Holcomb CN; Graham LA; Richman JS; Rhyne RR; Itani KM; Maddox TM; Hawn MT
    J Am Coll Cardiol; 2014 Dec; 64(25):2730-9. PubMed ID: 25541124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP; Farah B; Fajadet J; Marco J
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
    Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
    Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Myocardial Infarction and Death After Noncardiac Surgery Performed Within the First Year After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome or Stable Angina Pectoris.
    Thim T; Egholm G; Kristensen SD; Olesen KKW; Madsen M; Jensen SE; Jensen LO; Sørensen HT; Bøtker HE; Maeng M
    Am J Cardiol; 2021 Dec; 160():14-20. PubMed ID: 34583812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary angiography and failure to rescue after postoperative myocardial infarction in patients with coronary stents undergoing noncardiac surgery.
    Hollis RH; Holcomb CN; Valle JA; Smith BP; DeRussy AJ; Graham LA; Richman JS; Itani KM; Maddox TM; Hawn MT
    Am J Surg; 2016 Nov; 212(5):814-822.e1. PubMed ID: 27640120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention.
    Ang L; Behnamfar O; Palakodeti S; Lin F; Pourdjabbar A; Patel MP; Reeves RR; Mahmud E
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary analysis of incidence and outcomes of stent thrombosis presenting as ST elevation myocardial infarction in a primary percutaneous coronary intervention cohort.
    Jones DA; Gallagher S; Rathod KS; Akhtar M; Knight CJ; Rothman MT; Kapur A; Mathur A; Jain AK; Timmis AD; Smith EJ; Wragg A
    Am J Cardiol; 2013 Nov; 112(9):1347-54. PubMed ID: 24012030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Post-TKA Acute Myocardial Infarction in Patients With a History of Myocardial Infarction or Coronary Stent.
    Kumar A; Tsai WC; Tan TS; Chiu LT; Kung PT; Lo CK; Ku MC
    Clin Orthop Relat Res; 2016 Feb; 474(2):479-86. PubMed ID: 26566978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
    Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL;
    JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Serum Fibrinogen, Total Stent Length, and Type of Acute Coronary Syndrome on 6-Month Major Adverse Cardiovascular Events and Bleeding After Percutaneous Coronary Intervention.
    Mahmud E; Ramsis M; Behnamfar O; Enright K; Huynh A; Kaushal K; Palakodeti S; Li S; Teh P; Lin F; Reeves R; Patel M; Ang L
    Am J Cardiol; 2016 May; 117(10):1575-1581. PubMed ID: 27040574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study.
    Dohi T; Mintz GS; McPherson JA; de Bruyne B; Farhat NZ; Lansky AJ; Mehran R; Weisz G; Xu K; Stone GW; Maehara A
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):908-16. PubMed ID: 23850249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention.
    Jensen LO; Kaltoft A; Thayssen P; Tilsted HH; Christiansen EH; Mikkelsen KV; Maeng M; Hansen KN; Villadsen AB; Madsen M; Lassen JF; Pedersen KE; Thuesen L
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):101-8. PubMed ID: 19670299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.